Wilkens LR - Search Results

1

Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.

Le Marchand L, Sivaraman L, Pierce L, Seifried A, Lum A, Wilkens LR, Lau AF. Le Marchand L, et al. Among authors: wilkens lr. Cancer Res. 1998 Nov 1;58(21):4858-63. Cancer Res. 1998. PMID: 9809991

2

Ethnic differences in the lung cancer risk associated with smoking.

Le Marchand L, Wilkens LR, Kolonel LN. Le Marchand L, et al. Among authors: wilkens lr. Cancer Epidemiol Biomarkers Prev. 1992 Jan-Feb;1(2):103-7. Cancer Epidemiol Biomarkers Prev. 1992. PMID: 1306091

3

CYP1A1 genetic polymorphisms and in situ colorectal cancer.

Sivaraman L, Leatham MP, Yee J, Wilkens LR, Lau AF, Le Marchand L. Sivaraman L, et al. Among authors: wilkens lr. Cancer Res. 1994 Jul 15;54(14):3692-5. Cancer Res. 1994. PMID: 7913406

4

Predictors of N-acetyltransferase activity: should caffeine phenotyping and NAT2 genotyping be used interchangeably in epidemiological studies?

Le Marchand L, Sivaraman L, Franke AA, Custer LJ, Wilkens LR, Lau AF, Cooney RV. Le Marchand L, et al. Among authors: wilkens lr. Cancer Epidemiol Biomarkers Prev. 1996 Jun;5(6):449-55. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 8781741

5

Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer.

Le Marchand L, Wilkens LR, Kolonel LN, Hankin JH, Lyu LC. Le Marchand L, et al. Among authors: wilkens lr. Cancer Res. 1997 Nov 1;57(21):4787-94. Cancer Res. 1997. PMID: 9354440

6

Association of the NAD(P)H:quinone oxidoreductase 609C-->T polymorphism with a decreased lung cancer risk.

Chen H, Lum A, Seifried A, Wilkens LR, Le Marchand L. Chen H, et al. Among authors: wilkens lr. Cancer Res. 1999 Jul 1;59(13):3045-8. Cancer Res. 1999. PMID: 10397241

7

Intake of flavonoids and lung cancer.

Le Marchand L, Murphy SP, Hankin JH, Wilkens LR, Kolonel LN. Le Marchand L, et al. Among authors: wilkens lr. J Natl Cancer Inst. 2000 Jan 19;92(2):154-60. doi: 10.1093/jnci/92.2.154. J Natl Cancer Inst. 2000. PMID: 10639518

8

Association of the myeloperoxidase -463G-->a polymorphism with lung cancer risk.

Le Marchand L, Seifried A, Lum A, Wilkens LR. Le Marchand L, et al. Among authors: wilkens lr. Cancer Epidemiol Biomarkers Prev. 2000 Feb;9(2):181-4. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10698479

9

CYP1A1, GSTM1, and GSTP1 genetic polymorphisms and urinary 1-hydroxypyrene excretion in non-occupationally exposed individuals.

Nerurkar PV, Okinaka L, Aoki C, Seifried A, Lum-Jones A, Wilkens LR, Le Marchand L. Nerurkar PV, et al. Among authors: wilkens lr. Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1119-22. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 11045797

10

Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population.

Pierce LM, Sivaraman L, Chang W, Lum A, Donlon T, Seifried A, Wilkens LR, Lau AF, Le Marchand L. Pierce LM, et al. Among authors: wilkens lr. Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1199-204. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 11097227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

655 results

Search Page

Filters